Can Diagnostic Revenues Drive PerkinElmer (PKI) Q3 Earnings?

by Zacks Equity Research Published on October 24,2018

PerkinElmer (PKI) likely to gain from strong segmental revenues in Q3; a raised earnings guidance for 2018 is promising.

• PKI Quick QuotePKIPositive Net Change
• MASI Quick QuoteMASINegative Net Change
• BDX Quick QuoteBDXNegative Net Change
• MCK Quick QuoteMCKPositive Net Change

• medical

Why Is PerkinElmer (PKI) Up 7% Since Last Earnings Report?

by Zacks Equity Research Published on August 31,2018

PerkinElmer (PKI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

• PKI Quick QuotePKIPositive Net Change

PerkinElmer (PKI) Q2 Earnings & Revenues Top, EPS View Up

by Zacks Equity Research Published on August 02,2018

Solid performance by PerkinElmer's (PKI) DAS and Diagnostics arms is a key positive in Q2. The company saw strength across all major geographies in Asia, Americas, Europe and the BRIC nations.

• PKI Quick QuotePKIPositive Net Change
• ISRG Quick QuoteISRGPositive Net Change
• CHE Quick QuoteCHEPositive Net Change
• ALGN Quick QuoteALGNPositive Net Change

PerkinElmer (PKI) Tops Q2 Earnings and Revenue Estimates

by Zacks Equity Research Published on August 01,2018

PerkinElmer (PKI) delivered earnings and revenue surprises of 5.81% and 1.38%, respectively, for the quarter ended June 2018. Do the numbers hold clues to what lies ahead for the stock?

• PKI Quick QuotePKIPositive Net Change

Should You Buy PerkinElmer (PKI) Ahead of Earnings?

by Zacks Equity Research Published on August 01,2018

PerkinElmer (PKI) is seeing favorable earnings estimate revision activity as of late, which is generally a precursor to an earnings beat.

• PKI Quick QuotePKIPositive Net Change

Can Solid European Sales Boost Inogen (INGN) in Q2 Earnings?

by Zacks Equity Research Published on July 30,2018

Strong performance in Europe is likely to boost Inogen's (INGN) top line in Q2. However, decline rental-revenues is a concern.

• PKI Quick QuotePKIPositive Net Change
• INGN Quick QuoteINGNPositive Net Change
• STE Quick QuoteSTENegative Net Change
• CAH Quick QuoteCAHNegative Net Change

What's in Store for Pacific Biosciences' (PACB) Q2 Earnings?

by Zacks Equity Research Published on July 27,2018

Pacific Biosciences' (PACB) flagship Sequel System is likely to drive Q2 results; competition is a headwind.

• TFX Quick QuoteTFXPositive Net Change
• PKI Quick QuotePKIPositive Net Change
• PACB Quick QuotePACBNegative Net Change
• COO Quick QuoteCOONegative Net Change

Can Kidney Care Business Drive DaVita's (DVA) Q2 Earnings?

by Zacks Equity Research Published on July 26,2018

DaVita's (DVA) flagship Kidney Care business likely to drive Q2 results; solid international presence encourages.

• TFX Quick QuoteTFXPositive Net Change
• PKI Quick QuotePKIPositive Net Change
• DVA Quick QuoteDVAPositive Net Change
• COO Quick QuoteCOONegative Net Change

Can R&D Focus Drive DENTSPLY SIRONA's (XRAY) Q2 Earnings?

by Zacks Equity Research Published on July 24,2018

DENTSPLY SIRONA's (XRAY) continued focus on research and development and strategic buyouts are likely to drive Q2 results.

• TFX Quick QuoteTFXPositive Net Change
• PKI Quick QuotePKIPositive Net Change
• EW Quick QuoteEWPositive Net Change
• XRAY Quick QuoteXRAYNegative Net Change

What's in Store for Cerner (CERN) This Earnings Season?

by Zacks Equity Research Published on July 23,2018

Cerner's (CERN) Q2 results are likely to show softer performance owing to declining revenues across core business segments.

• CERN Quick QuoteCERNPositive Net Change
• TFX Quick QuoteTFXPositive Net Change
• PKI Quick QuotePKIPositive Net Change
• EW Quick QuoteEWPositive Net Change

What's in Store for AmerisourceBergen (ABC) in Q3 Earnings?

by Zacks Equity Research Published on July 20,2018

AmerisourceBergen's (ABC) Q3 results are likely to be driven by its core Pharmaceutical Distribution business; a competitive industry is a headwind.

• TFX Quick QuoteTFXPositive Net Change
• PKI Quick QuotePKIPositive Net Change
• EW Quick QuoteEWPositive Net Change
• ABC Quick QuoteABCPositive Net Change

Can BD Medical Drive Becton, Dickinson's (BDX) Q3 Earnings?

by Zacks Equity Research Published on July 19,2018

Becton, Dickinson's (BDX) core BD Medical likely to register solid results in Q3; a possible decline in BD Life Sciences raises concern.

• TFX Quick QuoteTFXPositive Net Change
• PKI Quick QuotePKIPositive Net Change
• EW Quick QuoteEWPositive Net Change
• BDX Quick QuoteBDXNegative Net Change

Can Business Services Aid athenahealth's (ATHN) Q2 Earnings?

by Zacks Equity Research Published on July 19,2018

athenahealth's (ATHN) core Business Services unit is likely to drive growth in Q2; the company's focus on cloud-based services is encouraging.

• ATHN Quick QuoteATHNNo Net Change
• TFX Quick QuoteTFXPositive Net Change
• PKI Quick QuotePKIPositive Net Change
• EW Quick QuoteEWPositive Net Change

Can Diagnostic Revenues Drive PerkinElmer (PKI) Q2 Earnings?

by Zacks Equity Research Published on July 19,2018

Strong performance in the Diagnostics Segment is likely to drive PerkinElmer's (PKI) Q2 results. The segment fortifies the company's market position in terms of exclusiveness of services.

• PKI Quick QuotePKIPositive Net Change
• BAX Quick QuoteBAXNegative Net Change
• DXCM Quick QuoteDXCMPositive Net Change
• BIO Quick QuoteBIONegative Net Change

Zacks Industry Outlook Highlights: Waters, Mettler-Toledo and PerkinElmer

by Zacks Equity Research Published on July 16,2018

Zacks Industry Outlook Highlights: Waters, Mettler-Toledo and PerkinElmer

• WAT Quick QuoteWATNegative Net Change
• PKI Quick QuotePKIPositive Net Change
• MTD Quick QuoteMTDNegative Net Change

Instruments - Scientific Outlook: Growth Prospects Abound

by Aniruddha Ganguly Published on July 13,2018

Instruments - Scientific industry's growth prospect is quite bright in the near term given rising spending by the government and academic labs.

• MTD Quick QuoteMTDNegative Net Change
• PKI Quick QuotePKIPositive Net Change
• WAT Quick QuoteWATNegative Net Change

Here's Why You Should Invest in PerkinElmer (PKI) Stock Now

by Zacks Equity Research Published on May 31,2018

PerkinElmer (PKI) gains from stellar Q1 performance; a raised guidance holds promise.

• PKI Quick QuotePKIPositive Net Change
• VAR Quick QuoteVARPositive Net Change
• ISRG Quick QuoteISRGPositive Net Change
• ABMD Quick QuoteABMDPositive Net Change

PerkinElmer (PKI) Q1 Earnings & Revenues Top, '18 View Up

by Zacks Equity Research Published on May 01,2018

Solid prospects in PerkinElmer's (PKI) DAS segment are the key drivers of Q1. Strength in life sciences end markets, informatics profile and OneSource have given the top line a boost.

• PKI Quick QuotePKIPositive Net Change
• VAR Quick QuoteVARPositive Net Change
• ISRG Quick QuoteISRGPositive Net Change

Is a Surprise Coming for PerkinElmer (PKI) This Earnings Season?

by Zacks Equity Research Published on April 26,2018

PerkinElmer (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP.

• PKI Quick QuotePKIPositive Net Change

Can Diagnostic Revenues Drive PerkinElmer (PKI) Q1 Earnings?

by Zacks Equity Research Published on April 19,2018

PerkinElmer (PKI) gains from EUROIMMUN buyout, solid guidance buoys optimism.

• PKI Quick QuotePKIPositive Net Change
• HOLX Quick QuoteHOLXPositive Net Change
• SYK Quick QuoteSYKPositive Net Change

DENTSPLY to Acquire OraMetrix, Boost CAD-CAM Dental Unit

by Zacks Equity Research Published on March 27,2018

The acquisition of OraMetrix is likely to bolster DENTSPLY's (XRAY) dental business.

• ATHN Quick QuoteATHNNo Net Change
• PKI Quick QuotePKIPositive Net Change
• BIO Quick QuoteBIONegative Net Change
• XRAY Quick QuoteXRAYNegative Net Change

Here's Why You Should Invest in athenaheath Stock Right Now

by Zacks Equity Research Published on March 27,2018

athenahealth's (ATHN) strong product portfolio is likely to expand its customer base in the coming quarters.

• ATHN Quick QuoteATHNNo Net Change
• PKI Quick QuotePKIPositive Net Change
• VAR Quick QuoteVARPositive Net Change

Luminex (LMNX) Product Portfolio Solid, Competition Rife

by Zacks Equity Research Published on March 26,2018

Luminex's (LMNX) flagship VERIGENE and ARIES systems are likely to boost its growth trajectory.

• ATHN Quick QuoteATHNNo Net Change
• PKI Quick QuotePKIPositive Net Change
• LMNX Quick QuoteLMNXPositive Net Change

3 Reasons Why You Should Invest in Fresenius Medical Now

by Zacks Equity Research Published on March 22,2018

Wide range of dialysis products, deliberate initiatives to gain market traction and solid international foothold are major catalysts for Fresenius Medical (FMS) at the moment.

• ATHN Quick QuoteATHNNo Net Change
• PKI Quick QuotePKIPositive Net Change
• FMS Quick QuoteFMSNegative Net Change

Favorable Market Trend & Core Business Expansion Aid STERIS

by Zacks Equity Research Published on March 21,2018

STERIS' (STE) string of six buyouts in fiscal 2018 keeps us upbeat about the stock. The same is expected to strengthen its Healthcare Specialty Services and Applied Sterilization Technologies arms.

• ATHN Quick QuoteATHNNo Net Change
• PKI Quick QuotePKIPositive Net Change
• BIO Quick QuoteBIONegative Net Change